Marisa Peluso, MS

Monte Rosa Therapeutics
Boston, Massachusetts, United States

Director Non-Oncology Biology

Presentation(s):

• 0009: MRT-6160, a VAV1-Directed Molecular Glue Degrader, Attenuates T and B Cell Effector Functions and Inhibits Disease Progression in a Spontaneous MRL-Fas^lpr Mouse Model

  Sunday, October 26, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): Monte Rosa Therapeutics: Employee (Ongoing), Equity interest (Ongoing)